Treatment for chronic idiopathic constipation: Use and satisfaction from a nationwide survey of US participants
Neurogastroenterology & Motility · 2024-10 · 36 (10)
DOI: 10.1111/nmo.14885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, online erschienen am 18.08.2024. Verfasst von Brian E Lacy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA. Hauptthemen laut MEDLINE: Constipation, Patient Satisfaction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AbbVie Inc., Ironwood Pharmaceuticals, Inc., AbbVie.
Abstract (Originalsprache)
Background
Chronic idiopathic constipation (CIC) is a disorder of gut–brain interaction characterized by a variety of bowel movement‐related and abdominal symptoms. A greater understanding of medication use and satisfaction with symptom control may provide insights to optimize patient care. Therefore, we explored these aspects of the disorder in adults with CIC.
Methods
This study assessed data collected from a large nationwide survey of adult participants in the United States, querying demographics, clinical characteristics, and comorbid conditions, as well as medication use, care‐seeking behaviors, and satisfaction with symptom control. Participants were grouped into the CIC cohort if they met Rome IV criteria, with controls matched 1:1 according to age, sex, race, region, and Charlson Comorbidity Index score. All data were self‐reported. Key Results Two thousand five hundred and thirty‐three participants with CIC were matched 1:1 to controls. In the CIC cohort, abdominal pain was the most reported symptom leading to medication use: 15.9% of respondents were receiving a prescription medication in addition to an over‐the‐counter medication, while 26.3% were taking neither. In addition, only one‐third were satisfied with the control of their symptoms; however, satisfaction was significantly higher in respondents taking a prescription medication ( p < 0.001). The proportion of reported comorbidities was significantly higher in the CIC cohort versus the control cohort, with chronic pain, anxiety, and depression among the highest ( p < 0.001 for all). Conclusions and Inferences This study emphasizes the need for better communication regarding prescription medications and their benefits, with the goal of further improving CIC patients' overall symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.
- AbbVie Inc., North Chicago, Illinois, USA.
- Former employee of Ironwood Pharmaceuticals, Boston, Massachusetts, USA.
- Acumen Health Research Institute, Ann Arbor, Michigan, USA.
- YourCareChoice, Ann Arbor, Michigan, USA.
- International Foundation for Gastrointestinal Disorders, Milwaukee, Wisconsin, USA.
ORCID-Profile: Brian E Lacy
Förderung
- AbbVie Inc.
- Ironwood Pharmaceuticals, Inc.
- AbbVie
- Ironwood Pharmaceuticals, Incorporated
Zitieren
APA
Lacy, B. E., Xu, Y., Taylor, D. C. A., Kosch, K. J., Dobrescu, R., Morlock, A., Morlock, R., & Rooker, C. (2024). Treatment for chronic idiopathic constipation: Use and satisfaction from a nationwide survey of US participants. Neurogastroenterology & Motility, 36(10). https://doi.org/10.1111/nmo.14885
Vancouver
Lacy BE, Xu Y, Taylor DCA, Kosch KJ, Dobrescu R, Morlock A, et al. Treatment for chronic idiopathic constipation: Use and satisfaction from a nationwide survey of US participants. Neurogastroenterology & Motility. 2024;36(10). doi:10.1111/nmo.14885
BibTeX
@article{Lacy2024,
author = {Lacy, Brian E and Xu, Yanqing and Taylor, Douglas C A and Kosch, Katherine J and Dobrescu, Rachel and Morlock, Amy and Morlock, Robert and Rooker, Ceciel},
title = {Treatment for chronic idiopathic constipation: Use and satisfaction from a nationwide survey of US participants},
journal = {Neurogastroenterology & Motility},
year = {2024},
volume = {36},
number = {10},
doi = {10.1111/nmo.14885}
}
EUVIMED